Information:
Error:
ID
34207
Description
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01679327
Link
https://clinicaltrials.gov/show/NCT01679327
Keywords
Versions (1)
- 1/15/19 1/15/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 15, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Colorectal Cancer NCT01679327
Eligibility Colorectal Cancer NCT01679327
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT01679327
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
more than 18-years old,male or female
boolean
ID.2
Item
pathologically approved as unresectable/metastatic colorectal cancer
boolean
ID.3
Item
kps > 70% or ecog 0-2
boolean
ID.4
Item
hgb > 80 g/l, neut ≥ 1.5x109 /l, plt ≥ 80x109 /l; cr < 1.5 x upper normality，
boolean
ID.5
Item
tb < 1.5 x upper normality，ast or alt < 2.5 x upper normality.
boolean
ID.6
Item
signed consent
boolean
ID.7
Item
other malignancies simultaneously except in situ cervix or nonmelanoma skin cancer
boolean
ID.8
Item
pregnancy or in lactation
boolean
ID.9
Item
hgb < 80 g/l, neut < 1.5x109 /l, plt < 80x109 /l; cr ≥ 1.5 x upper normality， tb ≥
boolean
ID.10
Item
2.5 x upper normality，ast or alt ≥2.5 x upper normality，akp ≥ 2.5 x upper normality
boolean